Trending menu:
Oncology
-
22 March 2019 News
Health Quest to deploy IBM Watson for Clinical Trial Matching
Health Quest Systems has signed an agreement to deploy IBM Watson for Clinical Trial Matching, a cognitive computing system, to increase participation in clinical trials.
-
6 March 2019 News
ORNL researchers develop AI based tool to match cancer patients with clinical trials
A team of researchers from the Department of Energy’s (DOE) Oak Ridge National Laboratory (ORNL) Health Data Sciences Institute in the US has developed an artificial intelligence (AI) based digital...
-
5 March 2019 Digital Disruption
Embleema, Gustave Roussy to develop blockchain-based applications for cancer research
Embleema has partnered with Gustave Roussy Institut to develop blockchain-based health data sharing applications to accelerate cancer research.
-
26 February 2019 News
Analysis finds increasing early-stage trials for rare cancers
A new analysis by the National Cancer Center Hospital in Japan has found that the focus of early-stage clinical trials is shifting from major cancer killers to rare types of...
-
19 February 2019 News
Leukemia & Lymphoma Society to adopt Saama LSAC in Beat AML trial
US-based non-profit Leukemia & Lymphoma Society (LLS) has partnered with data analytics company Saama Technologies to implement Life Science Analytics Cloud (LSAC) in its Beat AML Master Clinical Trial. Saama’s...
-
6 February 2019 Analysis
Sandoz Abandons US Development of Rixathon
Chloé Thépaut, MRes, Oncology Senior Analyst, GlobalData, examines the implications of Sandoz’s abandoned attempt to have Rixathon approved in the US
-
30 January 2019 Comment
Industry Viewpoints: Patient Recruitment and Expanded Access
In the latest Industry Viewpoint, Howard Fingert speaks to CTA’s Elizabeth Williams about the challenges of patient recruitment
-
12 December 2018 News
Industry Viewpoints: Choosing the Right CRO
In this Industry Viewpoint, CTA’s Elizabeth Williams speaks with Philip Arlen to discuss key considerations when formulating an outsourcing strategy
-
30 November 2018 Comment
The United Kingdom of Green Britain
As medicinal cannabis hits the U.K., CTA’s Harry Parsons takes a look at the ground-breaking reform taking place and how it could impact clinical research
-
19 October 2018 Analysis
Expert Insights: EMA Reinforces Stance on Biosimilar Use for Sustainable Health Care in New Educational Video
Chloé Thépaut, MRes, Oncology Senior Analyst, GlobalData, examines the importance of the EMA’s efforts to improve patient and physician education on biosimilar medicines